4//SEC Filing
Drake Neil 4
Accession 0001214659-18-000895
CIK 0001427570other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:14 PM ET
Size
18.1 KB
Accession
0001214659-18-000895
Insider Transaction Report
Form 4
Drake Neil
VP of Research and Development
Transactions
- Exercise/Conversion
Common Stock
2018-02-02$1.83/sh+5,746$10,515→ 13,899 total - Exercise/Conversion
Common Stock
2018-02-02$1.77/sh+4,310$7,629→ 21,850 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-02-02−229→ 0 totalExercise: $1.31From: 2014-10-08Exp: 2021-01-26→ Common Stock (229 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2018-02-02−5,746→ 0 totalExercise: $1.83From: 2016-06-14Exp: 2022-08-14→ Common Stock (5,746 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2018-02-02−4,310→ 6,034 totalExercise: $1.77Exp: 2026-05-11→ Common Stock (4,310 underlying) - Exercise/Conversion
Common Stock
2018-02-02$1.31/sh+229$300→ 8,153 total - Exercise/Conversion
Common Stock
2018-02-02$0.76/sh+3,641$2,767→ 17,540 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-02-02−3,641→ 1,083 totalExercise: $0.76Exp: 2025-03-04→ Common Stock (3,641 underlying)
Footnotes (2)
- [F1]This option vests as to 25% of the total shares on January 1, 2016, then 2.083% monthly, with 100% of the total shares vested on January 1, 2019, subject to the reporting person's provision of service to the Issuer on each vesting date.
- [F2]This option vests as to 2.083% of the total shares monthly, commencing on May 11, 2016, with 100% of the total shares vested on May 11, 2020, subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001698005
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:14 PM ET
- Size
- 18.1 KB